1.63  0.02 (1.24%)		10-09 15:42
Open: 1.69 High: 1.69 Volume: 47,060		Pre. Close: 1.61 Low: 1.62 Market Cap: 31(M)

Short term
Mid term
Targets	6-month :	2.22	1-year :	2.51
Resists	First :	1.9	Second :	2.15
Pivot price	1.71
Supports	First :	1.5	Second :	1.25
MAs	MA(5) :	1.58	MA(20) :	1.76
	MA(100) :	2.28	MA(250) :	0
MACD	MACD :	-0.2	Signal :	-0.1
%K %D	K(14,3) :	15.7	D(3) :	8.2
RSI	RSI(14): 38.7
52-week	High :	9.39	Low :	0.91

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ BMGL ] has closed above bottom band by 28.4%. Bollinger Bands are 81% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for {EMPTY} bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	1.62 - 1.63	1.63 - 1.64
Low:	1.49 - 1.5	1.5 - 1.51
Close:	1.59 - 1.61	1.61 - 1.63

Basel Medical Group Ltd provides healthcare services. The company offers services in the areas of medical specialists, medical supplies and equipment, medical technology, and pharmaceuticals. The company was incorporated in 2023 and is based in Singapore.

Thu, 17 Jul 2025
Basel Medical Group Suspends Major Bitcoin Deal as US Regulatory Concerns Mount - Stock Titan

Mon, 02 Jun 2025
Best Penny Stocks To Keep An Eye On - June 2nd - MarketBeat

Mon, 02 Jun 2025
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket - Benzinga

Fri, 30 May 2025
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Thu, 22 May 2025
Singapore-based Basel Medical takes the orange pill with $1B BTC plan - Cryptopolitan

Thu, 22 May 2025
Basel Medical Group Ltd Announces Strategic Purchase Agreement for 10,000 BTC to Diversify Treasury Reserves - Nasdaq

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Plans
Shares Out	19 (M)
Shares Float	5 (M)
Held by Insiders	67.8 (%)
Held by Institutions	0.6 (%)
Shares Short	361 (K)
Shares Short P.Month	487 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.44
Profit Margin	4.2 %
Operating Margin	-11.4 %
Return on Assets (ttm)	-1.3 %
Return on Equity (ttm)	6 %
Qtrly Rev. Growth	-1 %
Gross Profit (p.s.)	0.15
Sales Per Share	0.53
EBITDA (p.s.)	-0.02
Qtrly Earnings Growth	0 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	11 (M)

PE Ratio	162.05
PEG Ratio	0
Price to Book value	3.6
Price to Sales	3.03
Price to Cash Flow	-21.45

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.